“To ensure the health and safety of all our attendees, CRF has transitioned our in-person TCT conference to a compelling and unique virtual experience,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF. “TCT Connect will deliver the high-quality education, training, and clinical science our meeting attendees have come to expect along with new ways to learn and engage with each other online.”
Additional details on TCT Connect will be announced soon. For more information, visit https://www.crf.org/tct.
The Cardiovascular Research Foundation (CRF) is one of the world’s leading nonprofit organizations specializing in interventional cardiology innovation, research, and education. CRF is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For nearly 30 years, CRF has helped pioneer medical advances and educated doctors on the latest treatments for heart disease. CRF is comprised of the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team.
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the premier educational meeting specializing in interventional cardiovascular medicine. Now in its 32nd year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.
Original post https://alertarticles.info